Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer

Omega-3 fatty acids and protein metabolism

(2014) Filippo Giorgio Di Girolamo et al.   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study

(2014) David S Hong et al.   LANCET ONCOLOGY

Sarcopenia Is Linked to Treatment Toxicity in Patients With Metastatic Colorectal Cancer

(2014) Maximilien Barret et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

Does IGFR1 inhibition result in increased muscle mass loss in patients undergoing treatment for pancreatic cancer?

(2014) David R. Fogelman et al.   Journal of Cachexia Sarcopenia and Muscle

Are we closer to having drugs to treat muscle wasting disease?

(2014) John E. Morley et al.   Journal of Cachexia Sarcopenia and Muscle

An overview of amines as nutritional supplements to counteract cancer cachexia

(2014) Patrícia Lopes de Campos-Ferraz et al.   Journal of Cachexia Sarcopenia and Muscle

Rehabilitation nutrition for sarcopenia with disability: a combination of both rehabilitation and nutrition care management

(2014) Hidetaka Wakabayashi et al.   Journal of Cachexia Sarcopenia and Muscle

Borderline Resectable Pancreatic Cancer: Need for Standardization and Methods for Optimal Clinical Trial Design

(2013) Matthew H. G. Katz et al.   ANNALS OF SURGICAL ONCOLOGY

Quantitative Measures of Visceral Adiposity and Body Mass Index in Predicting Rectal Cancer Outcomes after Neoadjuvant Chemoradiation

(2013) Whalen Clark et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Effect of total-body prehabilitation on postoperative outcomes: a systematic review and meta-analysis

(2013) D. Santa Mina et al.   Physiotherapy

Accelerated muscle and adipose tissue loss may predict survival in pancreatic cancer patients: the relationship with diabetes and anaemia

(2012) Katie M. Di Sebastiano et al.   BRITISH JOURNAL OF NUTRITION

Impact of Sarcopenia on Outcomes Following Resection of Pancreatic Adenocarcinoma

(2012) Peter Peng et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Relationships Among Body Mass Index, Longitudinal Body Composition Alterations, and Survival in Patients With Locally Advanced Pancreatic Cancer Receiving Chemoradiation: A Pilot Study

(2012) Shalini Dalal et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

The Relationship Between Body Composition and Response to Neoadjuvant Chemotherapy in Women with Operable Breast Cancer

(2012) E. Del Fabbro et al.   ONCOLOGIST

Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer

(2011) Sherif Awad et al.   CLINICAL NUTRITION

Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer

(2009) B. H.L. Tan et al.   CLINICAL CANCER RESEARCH

A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care

(2008) Marina Mourtzakis et al.   Applied Physiology Nutrition and Metabolism

Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head

(2008) Gauri R. Varadhachary et al.   JOURNAL OF CLINICAL ONCOLOGY

Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head

(2008) Douglas B. Evans et al.   JOURNAL OF CLINICAL ONCOLOGY